Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CMMB

Chemomab Therapeutics (CMMB) stock: insider trades, news & valuation

Net selling
Close · Oct 9, 2026 $1.38 -0.7% on the day -59.1% over 12 months 52-week range $1.19 – $3.45

Share price and insider trades

CMMB closeInsider buyInsider sale
1234NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $2,800 on 2026-08-28 · Neil Harris CohenSold $3,716 on 2026-08-27 · Neil Harris CohenBought $20,246 on 2026-05-29 · George Adi Mor
Bought, 12 months$0
Sold, 12 months$7K
Insiders buying0
Insiders selling1

Chemomab Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $7K of CMMB stock on the open market.

CMMB insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $20K bought (2 trades)$20KQ2 2026Q3 2026: $7K sold (2 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$7K2
Q2 2026$20K2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.2×Last 5 sessions
Insiders' paper profit−$7KOn all tracked purchases -33.2%

Summary

Over the past 12 months, 0 Chemomab Therapeutics Ltd. insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $7K. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 1SEC Neil Harris CohenDirector Sell 1,30434,000 held (−4%) $2.85 $4K -51.6% —
Sep 1SEC Neil Harris CohenDirector Sell 1,00033,000 held (−3%) $2.80 $3K -50.7% —
Jun 1SEC George Adi MorCEO Buy 4,926139,131 held (+4%) $2.08 $10K -33.7% —
Jun 1SEC George Adi MorCEO Buy 4,878134,205 held (+4%) $2.05 $10K -32.7% —

Insiders at Chemomab Therapeutics Ltd.

InsiderBoughtSoldLast filingScore
George Adi MorCEO $20K — Jun 1, 2026 —
Neil Harris CohenDirector — $7K Sep 1, 2026 —

CMMB stock: common questions

Are Chemomab Therapeutics Ltd. insiders buying CMMB stock?

In the past 12 months, 0 insiders reported open-market purchases of CMMB worth $0. The latest was CEO George Adi Mor bought $10K of CMMB at $2.08.

Are Chemomab Therapeutics Ltd. insiders selling CMMB stock?

1 insiders reported sales worth $7K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CMMB's 52-week range?

Over the past year CMMB has traded between $1.19 and $3.45. It last closed at $1.38 on Oct 9, 2026.